|
Veronique Chotteau PhD
Professor and Director of AdBIOPRO
KTH
Stockholm
Sweden
|
"Professor Véronique Chotteau is Director of AdBIOPRO, Centre for Advanced Bioproduction by Continuous Processing and Head of the Cell Technology group, at the Dept. Industrial Biotechnology, School of Engineering Sciences in Chemistry, Biotechnology, and Health, KTH - Royal Institute of Technology, Stockholm, Sweden. AdBIOPRO is a highly multi-disciplinary Centre dedicated to biomanufacturing of biologics and gathering eight academic groups from KTH Royal Institute of Technology, Lund University, Karolinska Hospital, Karolinska Institutet and Linköping University, as well as 16 industrial partners, Alfa Laval, ArgusEye, AstraZeneca, BioInvent International, BioLamina, Cellcolabs, Cellevate, Cytiva, Merck KGaA Darmstadt Germany, Magic Bioprocessing, Metenova a company of Repligen, NorthX Biologics, Nyctea Technologies, Servier, TimeGate Instruments and Valneva.
Chotteau holds BSc Eng. Sciences, MSc Electrical Engineering, MSc Biotechnology, PhD Biotechnology/Automatic Control/Modelling (University of Louvain, Belgium). She has more than 30 years of experience in mammalian cell culture including ≥ 10 years in biopharmaceutical industry at Pharmacia Upjohn/Biovitrum, Stockholm, nowadays Swedish Orphan Biovitrum, working, among others, as Senior Project Manager for the development of recombinant drug protein based on mammalian cell cultivation, Head of Eucaryotic Pilot Plant, Responsible of development support for cGMP commercial recombinant factor VIII cultivation process, business development support. She joined KTH in 2008, when she was offered to lead the animal cell cultivation activities. Her group is focusing on cell-based processes for biologics production, high cell density perfusion of CHO and HEK293 cells, monitoring, automation, mathematical modelling for the production of glycoproteins, viral vectors and cells for human therapy. Chotteau is leader in perfusion process of established cell lines and was the first to publish cell densities higher than 200 millions cells/mL in CHO cell perfusion process. Her work is highly multi-disciplinary through extensive collaborations in academia and industry. She is currently co-PI in the Competence Centre for Advanced Medical Products, CAMP, in the Innovation Milieu GeneNova for a Safer, More Efficacious and Accessible AAV Gene Therapy and in the Digital Futures project Data-Limited Learning of Complex Dynamical Systems. She has been Coordinator of the EU projects iConsensus and HESUB. "
Chotteau holds BSc Eng. Sciences, MSc Electrical Engineering, MSc Biotechnology, PhD Biotechnology/Automatic Control/Modelling (University of Louvain, Belgium). She has more than 30 years of experience in mammalian cell culture including ≥ 10 years in biopharmaceutical industry at Pharmacia Upjohn/Biovitrum, Stockholm, nowadays Swedish Orphan Biovitrum, working, among others, as Senior Project Manager for the development of recombinant drug protein based on mammalian cell cultivation, Head of Eucaryotic Pilot Plant, Responsible of development support for cGMP commercial recombinant factor VIII cultivation process, business development support. She joined KTH in 2008, when she was offered to lead the animal cell cultivation activities. Her group is focusing on cell-based processes for biologics production, high cell density perfusion of CHO and HEK293 cells, monitoring, automation, mathematical modelling for the production of glycoproteins, viral vectors and cells for human therapy. Chotteau is leader in perfusion process of established cell lines and was the first to publish cell densities higher than 200 millions cells/mL in CHO cell perfusion process. Her work is highly multi-disciplinary through extensive collaborations in academia and industry. She is currently co-PI in the Competence Centre for Advanced Medical Products, CAMP, in the Innovation Milieu GeneNova for a Safer, More Efficacious and Accessible AAV Gene Therapy and in the Digital Futures project Data-Limited Learning of Complex Dynamical Systems. She has been Coordinator of the EU projects iConsensus and HESUB. "